SCHEMBL6172995

SCHEMBL6172995

COc1ccccc1NC(=O)CN1CCC(CN)CC1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.70
KMT2A Q03164 7/20 0.66
CYP2C19 P33261 3/20 0.65
CYP2D6 P10635 2/20 0.65
MEN1 O00255 6/20 0.64
TSHR P16473 3/20 0.64
MAPT P10636 2/20 0.64
LMNA P02545 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
NPSR1 Q6W5P4 4/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C9 P11712 2/20 0.61
USP2 O75604 1/20 0.61
CYP3A4 P08684 1/20 0.61
HTT P42858 1/20 0.61
RAB9A P51151 1/20 0.60
POLB P06746 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1644836 0.83 ALDH1A1 (0.97) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL6170356 0.83 ALDH1A1 (0.73) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL6169872 0.83 ALDH1A1 (0.76) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL1646961 0.82 ALDH1A1 (1.00) ALDH1A1KMT2ACYP2C19MEN1TSHR
SCHEMBL1644843 0.81 L3MBTL1 (0.79) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL1646834 0.80 ALDH1A1 (0.76) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL1643927 0.80 ALDH1A1 (0.76) ALDH1A1KMT2ACYP2C19MEN1TSHR
SCHEMBL1646962 0.80 ALDH1A1 (0.76) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL6175296 0.79 ALDH1A1 (0.74) ALDH1A1KMT2ACYP2C19CYP2D6MEN1
SCHEMBL3224693 0.78 NPC1 (0.63) ALDH1A1KMT2AMEN1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed